← Back to overview Language: NL EN

Our goal was to create a patent-free, low-cost COVID-19 vaccine that could be produced locally in low- and middle-income countries. This is about saving lives, not profits.

Maria Elena Bottazzi

TED Talk discussing the Corbevax vaccine development, 2022 · Checked on 14 March 2026
Our goal was to create a patent-free, low-cost COVID-19 vaccine that could be produced locally in low- and middle-income countries. This is about saving lives, not profits.

Analysis

Bottazzi and her team at Texas Children’s Hospital and Baylor College of Medicine developed **Corbevax** using traditional protein-subunit technology, explicitly rejecting patent protections to enable low-cost production. The vaccine was licensed to **Biological E. Limited (India)** and other manufacturers in **low- and middle-income countries (LMICs)**, with doses priced at **$1.50–$2**—far below mRNA alternatives. Bottazzi has consistently framed the project as a **humanitarian effort**, emphasizing local production to avoid supply-chain dependencies seen with patented vaccines. Independent reports (e.g., *Nature*, *STAT News*) confirm these goals and outcomes.

Background

Corbevax received **emergency use authorization in India (Dec 2021)** and later in **Botswana, Indonesia, and other LMICs**, though it faced delays in WHO EUL approval. The vaccine’s **open IP model** contrasts with Pfizer/Moderna’s patented mRNA vaccines, which faced criticism for inequitable distribution. Bottazzi’s work aligns with broader **global health equity movements**, such as the WHO’s COVID-19 Technology Access Pool (C-TAP).

Verdict summary

Maria Elena Bottazzi accurately described Corbevax as a patent-free, low-cost COVID-19 vaccine designed for equitable global access, prioritizing public health over profits.

Sources consulted

— Texas Children’s Hospital. (2021). *Corbevax: A Patent-Free COVID-19 Vaccine for Global Access*. [Press Release](https://www.texaschildrens.org/press-releases/2021/corbevax-covid-19-vaccine)
— Nature. (2022). *How a ‘no-patent’ COVID vaccine could change global access*. [Article](https://www.nature.com/articles/d41586-022-00126-7)
— STAT News. (2021). *The scientists who created a low-cost Covid-19 vaccine — and why they’re giving it away*. [Article](https://www.statnews.com/2021/12/15/corbevax-low-cost-covid-19-vaccine-patent-free/)
— World Health Organization. (2022). *C-TAP and the push for equitable vaccine access*. [Report](https://www.who.int/initiatives/covid-19-technology-access-pool)
— Baylor College of Medicine. (2022). *Corbevax: Development Timeline and Global Impact*. [Research Summary](https://www.bcm.edu/news/corbevax-vaccine-timeline)